Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-14 Purchase |
2020-10-19 8:49 pm |
FS Development Corp. | FSDC | FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner |
441,500 | $10 | $4,415,000 | 441,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-12 Option Award |
2021-04-14 4:06 pm |
N/A 2031-04-11 |
Gemini Therapeutics Inc. | GMTX | Piekos Brian Chief Financial Officer |
377,734 | $0 | 377,734 (Direct) |
View |
| 2021-04-12 Option Award |
2021-04-14 4:03 pm |
N/A 2031-04-11 |
Gemini Therapeutics Inc. | GMTX | Barone Samuel B. Chief Medical Officer |
255,212 | $0 | 255,212 (Direct) |
View |
| 2021-02-05 Option Award |
2021-04-07 4:08 pm |
N/A 2031-02-04 |
Gemini Therapeutics Inc. | GMTX | Strapps Walter Chief Scientific Officer |
79,094 | $0 | 79,094 (Direct) |
View |
| 2021-02-05 Option Award |
2021-04-07 4:08 pm |
N/A 2031-02-04 |
Gemini Therapeutics Inc. | GMTX | Ong Tuyen Director |
58,855 | $0 | 58,855 (Direct) |
View |
| 2021-02-05 Option Award |
2021-04-07 4:07 pm |
N/A 2031-02-04 |
Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director |
58,855 | $0 | 58,855 (Direct) |
View |
| 2021-02-05 Option Award |
2021-04-07 4:06 pm |
N/A 2031-02-04 |
Gemini Therapeutics Inc. | GMTX | Uknis Marc Chief Medical Officer |
277,117 | $0 | 277,117 (Direct) |
View |
| 2021-02-05 Option Award |
2021-04-07 4:04 pm |
N/A 2031-02-04 |
Gemini Therapeutics Inc. | GMTX | Redmond Precillia Chief People Officer |
77,450 | $0 | 77,450 (Direct) |
View |
| 2021-02-05 Option Award |
2021-04-07 4:03 pm |
N/A 2031-02-04 |
Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick President & CEO |
1,124,832 | $0 | 1,124,832 (Direct) |
View |
| 2021-02-05 Option Award |
2021-04-07 4:02 pm |
N/A 2031-02-04 |
Gemini Therapeutics Inc. | GMTX | Lauder Scott Chief Technology Officer |
243,996 | $0 | 243,996 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:21 pm |
N/A 2031-03-11 |
Gemini Therapeutics Inc. | GMTX | Ong Tuyen Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:18 pm |
N/A 2031-03-11 |
Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:37 pm |
N/A 2031-02-28 |
Gemini Therapeutics Inc. | GMTX | Strapps Walter Chief Scientific Officer |
99,133 | $0 | 99,133 (Direct) |
View |
Ownership |
2021-03-03 6:36 pm |
N/A 2028-08-27 |
Gemini Therapeutics Inc. | GMTX | Strapps Walter Chief Scientific Officer |
0 | $0 | 69,658 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 4:52 pm |
N/A 2031-02-22 |
Gemini Therapeutics Inc. | GMTX | Redmond Precillia Chief People Officer |
25,489 | $0 | 25,489 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 4:51 pm |
N/A 2031-02-22 |
Gemini Therapeutics Inc. | GMTX | Lauder Scott Chief Technology Officer |
272,615 | $0 | 272,615 (Direct) |
View |
Ownership |
2021-02-19 4:01 pm |
N/A 2031-02-03 |
Gemini Therapeutics Inc. | GMTX | Piekos Brian Chief Financial Officer |
0 | $0 | 43,580 (Direct) |
View |
Ownership |
2021-02-16 5:23 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | George Jean Director 10% Owner |
0 | $0 | 4,836,106 (Indirect) |
View |
Ownership |
2021-02-16 5:23 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Singapore L.P. Lightstone Singapore Associates LLC Carusi Michael A Plain Henry A JR 10% Owner |
0 | $0 | 4,836,106 (Indirect) |
View |
Ownership |
2021-02-11 1:47 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC 10% Owner |
0 | $0 | 5,254,365 (Direct) |
View |
Ownership |
2021-02-11 1:29 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | Rhodes Jason P Director |
0 | $0 | 5,254,365 (Indirect) |
View |
Ownership |
2021-02-10 5:48 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner |
0 | $0 | 5,826,224 (Direct) |
View |
Ownership |
2021-02-10 5:44 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | GORDON CARL L Director 10% Owner |
0 | $0 | 5,826,224 (Indirect) |
View |
Ownership |
2021-02-10 5:41 pm |
N/A 2030-10-15 |
Gemini Therapeutics Inc. | GMTX | Uknis Marc Chief Medical Officer |
0 | $0 | 238,445 (Direct) |
View |
Ownership |
2021-02-10 5:39 pm |
N/A 2030-10-15 |
Gemini Therapeutics Inc. | GMTX | Redmond Precillia Chief People Officer |
0 | $0 | 66,745 (Direct) |
View |
Ownership |
2021-02-10 5:37 pm |
N/A 2030-10-15 |
Gemini Therapeutics Inc. | GMTX | Ong Tuyen Director |
0 | $0 | 50,338 (Direct) |
View |
Ownership |
2021-02-10 5:33 pm |
N/A 2029-11-11 |
Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick President & CEO |
0 | $0 | 972,976 (Direct) |
View |
Ownership |
2021-02-10 5:32 pm |
N/A 2030-10-15 |
Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director |
0 | $0 | 50,338 (Direct) |
View |
Ownership |
2021-02-10 5:25 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | Lauder Scott Chief Technology Officer |
0 | $0 | 210,459 (Direct) |
View |
Ownership |
2021-02-10 5:23 pm |
N/A 2030-10-15 |
Gemini Therapeutics Inc. | GMTX | BELOFF GREGG Chief Financial Officer |
0 | $0 | 66,203 (Direct) |
View |
| 2021-02-05 Conversion |
2021-02-09 4:00 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | Tananbaum James B. Director |
2,928,750 | $0 | 3,370,250 (Indirect) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:00 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | Tananbaum James B. Director |
1,500,000 | $10 | 3,370,250 (Indirect) |
View |
| 2021-02-05 Conversion |
2021-02-09 3:04 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director by Deputization Director 10% Owner |
2,928,750 | $0 | 3,370,250 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 3:04 pm |
N/A N/A |
Gemini Therapeutics Inc. | GMTX | FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director by Deputization Director 10% Owner |
1,500,000 | $10 | 3,370,250 (Direct) |
View |
Ownership |
2020-10-27 4:13 pm |
N/A N/A |
FS Development Corp. | FSDC | Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner |
0 | $0 | 3,370,250 (Indirect) |
View |
Ownership(A) |
2020-08-19 9:14 pm |
N/A N/A |
FS Development Corp. | FSDC | FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC 10% Owner |
0 | $0 | 3,018,750 (Direct) |
View |
Ownership(A) |
2020-08-19 9:14 pm |
N/A N/A |
FS Development Corp. | FSDC | Tananbaum James B. President & CEO 10% Owner |
0 | $0 | 3,018,750 (Indirect) |
View |
Ownership |
2020-08-11 9:38 pm |
N/A N/A |
FS Development Corp. | FSDC | FS Development Holdings LLC 10% Owner |
0 | $0 | 3,018,750 (Direct) |
View |